Skip to main content

Table 2 Proportion of RSV hospitalizations by diagnosis and observation period

From: Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis

  

Total

Compliant

Non-compliant

p-value

  

(N = 5,003)

(N = 1,912)

(N = 3,091)

 

Post-index Period

RSV hospitalization

n

57

7

50

 
 

%

1.14

0.37

1.62

<0.001

RSV-like hospitalization

n

119

33

86

 
 

%

2.38

1.73

2.78

0.017

Full RSV Season

RSV hospitalization

n

88

9

79

 
 

%

1.76

0.47

2.56

<0.001

RSV-like hospitalization

n

154

38

116

 
 

%

3.08

1.99

3.75

<0.001